Retrospective Cohort Study of Rebif® Use in Pediatric Multiple Sclerosis (MS) Subjects (REPLAY)
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The aim of this retrospective study is to review and describe safety, tolerability and
efficacy of Rebif® (subcutaneous interferon [IFN]-beta-1a) in children and adolescents, using
information already recorded in medical records. The study duration is 13 July 2010 (first
data collected) to 13 July 2011 (last data collected). In this study, Data of the subjects
evaluated between 1997 and 2009 was observed.